Skip to content
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
Menu
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
General News
March 6, 2023
Emyria partners with Pax Centre for MDMA-assisted therapy
March 2, 2023
Blog: A Passion for Building Companies That Aim to Do Good
February 27, 2023
Emyria releases Half-Yearly Report
February 6, 2023
Emyria to expand MDMA programs following landmark TGA decision
January 30, 2023
Latest 4C Report Highlights Emyria Collaborations
January 29, 2023
Dosing Commences on EMD-RX5 Phase 3 Clinical Trial
January 18, 2023
Emyria in the Australian Financial Review on the future of psychedelics
January 12, 2023
Emyria receives $2m+ R&D tax incentive refund
December 22, 2022
Blog: Looking at 2022 and forward into 2023
December 14, 2022
Watch the video – Planet Microcap Showcase Presentation
Load More
Search
Search
Search
ASX News
General News
Publications
Thought Leadership
Uncategorised